Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $22.0 million.

  • Neurogene's Cash from Investing Activities rose 17591.66% to $22.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$118.2 million, marking a year-over-year decrease of 381180.53%. This contributed to the annual value of -$125.3 million for FY2024, which is 58859.46% down from last year.
  • Neurogene's Cash from Investing Activities amounted to $22.0 million in Q3 2025, which was up 17591.66% from $7.4 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Cash from Investing Activities peaked at $29.9 million during Q1 2024, and registered a low of -$102.6 million during Q4 2024.
  • Over the past 3 years, Neurogene's median Cash from Investing Activities value was -$82000.0 (recorded in 2023), while the average stood at -$10.5 million.
  • Within the past 5 years, the most significant YoY rise in Neurogene's Cash from Investing Activities was 10332413.79% (2024), while the steepest drop was 3522439.02% (2024).
  • Over the past 3 years, Neurogene's Cash from Investing Activities (Quarter) stood at $25.8 million in 2023, then crashed by 497.27% to -$102.6 million in 2024, then skyrocketed by 121.43% to $22.0 million in 2025.
  • Its Cash from Investing Activities stands at $22.0 million for Q3 2025, versus $7.4 million for Q2 2025 and -$45.0 million for Q1 2025.